38: Podcast: Visus presbyopia drop gets FDA IND OK

Optometry Times On the Air
09/04/2021 11 min Episodio 38
38: Podcast: Visus presbyopia drop gets FDA IND OK

Listen "38: Podcast: Visus presbyopia drop gets FDA IND OK"

Descargar episodio Ver en sitio original

Episode Synopsis


Play Video
Rhett Schiffman, MD, MD, MHSA, chief medical officer and head of research and development at Visus Therapeutics, talks with Gretchyn Bailey, NCLC, FAAO, editor in chief of Optometry Times® about Brimichol, the company’s presbyopia-correcting eyedrop that recently received FDA acceptance of its investigational new drug (IND) application.

More episodes of the podcast Optometry Times On the Air

81: NK Insights: An Interactive Corneal Sensitivity Testing Workshop 29/08/2025
80: The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management 31/07/2025
79: Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes 30/06/2025
78: Navigating the Glaucoma Therapeutic and Surgical Landscape from Conventional to Cutting Edge 30/06/2025
77: Practical Approaches to Modern Dry Eye Treatment and Management 27/06/2025
76: New Opportunities in Topical Glaucoma Management 31/01/2025
75: Expanding the treatment arsenal in glaucoma management 29/08/2024
74: CooperVision’s Give Brightly and Generation Sight programs foster new abilities for underserved communities 20/08/2024
74: Reimagining dry eye disease: Delineating the role of evaporation from inflammation and insights into optimizing treatment 16/08/2024
73: Optometrists, organizations provide insight for State of Dry Eye survey 07/08/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA